Results from METIS (EF-25), an international, multicenter phase III randomized study evaluating the efficacy and safety of tumor treating fields (TTFields) therapy in NSCLC patients with brain metastases. Conference

Mehta, Minesh P, Gondi, Vinai, Ahluwalia, Manmeet Singh et al. (2024). Results from METIS (EF-25), an international, multicenter phase III randomized study evaluating the efficacy and safety of tumor treating fields (TTFields) therapy in NSCLC patients with brain metastases. . JOURNAL OF CLINICAL ONCOLOGY, 42(16),

International Collaboration

cited authors

  • Mehta, Minesh P; Gondi, Vinai; Ahluwalia, Manmeet Singh; Roberge, David; Ilic, Rosanda; Sio, Terence Tai Weng; Trifiletti, Daniel Michael; Muanza, Thierry; Krpan, Ana Misir; Ramakrishna, Naren R; Fiveash, John B; Metellus, Philippe; Wang, Chiachien Jake; Feuvret, Loic; Freyschlag, Christian; Csoszi, Tibor; Brown, Paul D; Harat, Maciej

authors

date/time interval

  • May 29, 2024 -

publication date

  • June 1, 2024

published in

keywords

  • Life Sciences & Biomedicine
  • Oncology
  • Science & Technology

Location

  • ELECTR NETWORK

Conference

  • Special Clinical Science Symposia

publisher

  • LIPPINCOTT WILLIAMS & WILKINS

volume

  • 42

issue

  • 16